SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-395971
Filing Date
2013-10-10
Accepted
2013-10-10 07:15:34
Documents
9
Period of Report
2013-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d607857d6k.htm 6-K 12926
2 EX-99.1 d607857dex991.htm EX-99.1 432988
3 EX-99.2 d607857dex992.htm EX-99.2 100398
4 EX-99.3 d607857dex993.htm EX-99.3 27987
5 EX-99.4 d607857dex994.htm EX-99.4 10087
6 EX-99.5 d607857dex995.htm EX-99.5 10513
7 GRAPHIC g607857g42l25.jpg GRAPHIC 3776
8 GRAPHIC g607857g53d04.jpg GRAPHIC 10084
9 GRAPHIC g607857g92f10.jpg GRAPHIC 21879
  Complete submission text file 0001193125-13-395971.txt   645570
Mailing Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4
Business Address 2310 ALFRED-NOBEL BLVD. MONTREAL A8 H4S 2B4 514-336-7800
Theratechnologies Inc. (Filer) CIK: 0001512717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 001-35203 | Film No.: 131144602
SIC: 2834 Pharmaceutical Preparations